# ATZUMI
> **NDA217901** · New Drug Application · Sponsor: SATSUMA PHARMS · Approved 2025-04-30
## Drug
- **FDA Application Number:** NDA217901
- **Application type:** New Drug Application
- **Brand name:** ATZUMI
- **Generic name:** DIHYDROERGOTAMINE MESYLATE
- **Active ingredients:** DIHYDROERGOTAMINE MESYLATE
- **Dosage form:** POWDER
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** SATSUMA PHARMS
- **Manufacturer:** Satsuma Pharmaceuticals, Inc.
- **First approval:** 2025-04-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217901)
---
*MORVS · CC0 1.0*